A role for astrocytic insulin-like growth factor I receptors in the response to ischemic insult.

Cre deletion Insulin-like growth factor astrocytes neuroprotection stroke

Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
28 Nov 2023
Historique:
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 28 11 2023
Statut: aheadofprint

Résumé

Increased neurotrophic support, including insulin-like growth factor I (IGF-I), is an important aspect of the adaptive response to ischemic insult. However, recent findings indicate that the IGF-I receptor (IGF-IR) in neurons plays a detrimental role in the response to stroke. Thus, we investigated the role of astrocytic IGF-IR on ischemic insults using tamoxifen-regulated Cre deletion of IGF-IR in glial fibrillary acidic protein (GFAP) astrocytes, a major cellular component in the response to injury. Ablation of IGF-IR in astrocytes (GFAP-IGF-IR KO mice) resulted in larger ischemic lesions, greater blood-brain-barrier disruption and more deteriorated sensorimotor coordination. RNAseq detected increases in inflammatory, cell adhesion and angiogenic pathways, while the expression of various classical biomarkers of response to ischemic lesion were significantly increased at the lesion site compared to control littermates. While serum IGF-I levels after injury were decreased in both control and GFAP-IR KO mice, brain IGF-I mRNA expression show larger increases in the latter. Further, greater damage was also accompanied by altered glial reactivity as reflected by changes in the morphology of GFAP astrocytes, and relative abundance of ionized calcium binding adaptor molecule 1 (Iba 1) microglia. These results suggest a protective role for astrocytic IGF-IR in the response to ischemic injury.

Identifiants

pubmed: 38017004
doi: 10.1177/0271678X231217669
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271678X231217669

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Kentaro Suda (K)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Jaime Pignatelli (J)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
CIBERNED, Madrid, Spain.

Laura Genis (L)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
CIBERNED, Madrid, Spain.

Ana M Fernandez (AM)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
CIBERNED, Madrid, Spain.

Estrella Fernandez de Sevilla (EF)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
CIBERNED, Madrid, Spain.

Ines Fernandez de la Cruz (IF)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Andrea Pozo-Rodrigalvarez (A)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Maria L de Ceballos (ML)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Sonia Díaz-Pacheco (S)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Raquel Herrero-Labrador (R)

Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
CIBERNED, Madrid, Spain.

Ignacio Torres Aleman (IT)

CIBERNED, Madrid, Spain.
Achucarro Basque Center for Neuroscience, Leioa, Spain.
Ikerbasque Basque Foundation for Science, Bilbao, Spain.

Classifications MeSH